Cargando…
Assessment of N-terminal pro-B-type natriuretic peptide level in screening for atrial fibrillation in primary health care
BACKGROUND: Atrial fibrillation (AF), an important cause of thromboembolic events, is often silent and intermittent, thus presenting a diagnostic challenge. The aim of this study was to assess whether the plasma level of N-terminal pro-brain natriuretic peptide (NT-proBNP) is related to the presence...
Autores principales: | Ghazal, Faris, Theobald, Holger, Rosenqvist, Mårten, Al-Khalili, Faris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391046/ https://www.ncbi.nlm.nih.gov/pubmed/30807614 http://dx.doi.org/10.1371/journal.pone.0212974 |
Ejemplares similares
-
Feasibility and outcomes of atrial fibrillation screening using intermittent electrocardiography in a primary healthcare setting: A cross-sectional study
por: Ghazal, Faris, et al.
Publicado: (2018) -
Validity of daily self-pulse palpation for atrial fibrillation screening in patients 65 years and older: A cross-sectional study
por: Ghazal, Faris, et al.
Publicado: (2020) -
Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study
por: Kemp Gudmundsdottir, Katrin, et al.
Publicado: (2020) -
N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009) -
Relationship of atrial fibrillation and N terminal pro brain natriuretic peptide in heart failure patients
por: Nasab Mehrabi, Entezar, et al.
Publicado: (2023)